TT

Terumo Blood And Cell Technologies

www.terumobct.com link_icon

Company Research Report: Terumo Blood and Cell Technologies



Company Overview



  • Name: Terumo Blood and Cell Technologies

  • Mission: Unlocking the potential of blood and cells to do more for patients around the world.

  • Founded: Terumo Corporation was founded in 1921 by Dr. Shibasaburo Kitasato and other medical scientists.

  • Key People:

  • Antoinette Gawin: President and Chief Executive Officer

  • Rusty Spinney: Executive Vice President, Chief Financial Officer

  • Veerle d’Haenens: General Manager, Global Therapy Innovations

  • Tim Costello: General Manager, Plasma Innovations

  • Headquarters: Lakewood, Colorado, USA

  • Number of Employees: Over 7,900 team members

  • Revenue: No information is available

  • Known For: The company provides medical technology and insights to empower blood- and cell-based therapies globally.


Products



  • Trima Accel® Automated Blood Collection System Version 7:

  • Description: An advanced apheresis system that enhances the collection of blood components.

  • Key Features: Higher productivity, improved donor experience, and smart connectivity with enhanced software applications.


  • Reveos® Automated Blood Processing System:

  • Description: A system that automates whole blood processing into platelets, plasma, and red blood cells.

  • Key Features: Consistent product quality, improved throughput, and reduced operational complexity.


  • FINIA® Fill and Finish System:

  • Description: An automated system for preparing fluids for cryopreservation.

  • Key Features: Consists of a device, barcode scanner, touch screen monitor, and closed tubing sets.


  • Quantum Flex® Cell Expansion System:

  • Description: Automated cell expansion system allowing consistent expansion for various cell types.

  • Key Features: Process control for adherent cells, suspension cells, viral vectors, and exosomes.


  • Mirasol® Pathogen Reduction Technology System:

  • Description: Technology to reduce pathogens in blood products.

  • Key Features: Uses riboflavin and UV light, shown to reduce transfusion-transmitted infections.


Recent Developments



  • Automated Manufacturing in Latin America: Terumo BCT expands automation in cell and gene therapy manufacturing, focusing on scalability and affordability.

  • Reveos Launch in the USA: Introduced to Blood Centers of America to streamline blood processing.

  • Collaboration with Sanquin: 10-year agreement to automate blood processing facilities in the Netherlands with Reveos™ system.

  • Anthony Nolan Partnership: Opened a new stem cell collection center in partnership, using Spectra Optia™ Apheresis Systems for cell collection.


New Products and Features:
  • Recent launches include the Trima Accel Version 7 with its enhanced software applications and Reveos™ System in the USA.

  • Introduced Quantum Flex, optimizing cell therapy production.


Partnerships:
  • Collaborations with companies like Nova Biomedical for cell culture sensing and Charles River for automating cell and gene therapy platforms.


The information presented is current as of the latest available updates in 2024.